IVIG Shows No Impact on VTE Risk in Dermatomyositis Patients IVIG Shows No Impact on VTE Risk in Dermatomyositis Patients

The rate of venous thromboembolism did not increase in dermatomyositis patients treated with intravenous immunoglobulin, compared with those not treated with IVIG.MDedge News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news